Skip to main content
Log in

Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The incidence of severe adverse events (SAEs) and associated risk factors in hematopoietic cell transplantation donors needs to be clarified for related donors (relatives of the transplant recipient), whose criteria for donation are more lenient than for unrelated donors. Data from related donors registered in the Japanese national data registry database between 2005 and 2021 were evaluated to determine the association of short-term SAE incidence with donor characteristics at registration.

Fourteen of 4339 bone marrow (BM) donors (0.32%) and 54 of 10,684 peripheral blood stem cell (PBSC) donors (0.51%) experienced confirmed SAEs during the short donation period. No deaths were observed. Past medical history was a common risk factor for SAEs in both BM and PBSC donors. Age of 60 years or older and female sex were identified as risk factors for SAEs in PBSC donors. Female sex was also a risk factor for poor mobilization, which resulted in discontinuation of PBSC collection.

Although donors should be selected carefully, a certain level of safety is ensured for related donors in Japan. Donor safety should be further increased by improving the selection method for related donors and extending the follow-up period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Anderlini P, Korbling M, Dale D, Gratwohl A, Schmitz N, Stroncek D, et al. Allogeneic blood stem cell transplantation: considerations for donors. Blood. 1997;90:903–8.

    CAS  PubMed  Google Scholar 

  2. Halter J, Kodera Y, Ispizua AU, Greinix HT, Schmitz N, Favre G, et al. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica. 2009;94:94–101.

    Article  PubMed  Google Scholar 

  3. Horowitz MM, Confer DL. Evaluation of hematopoietic stem cell donors. Hematol Am Soc Hematol Educ Progr. 2005;2005:469–75.

    Article  Google Scholar 

  4. Halter JP, van Walraven SM, Worel N, Bengtsson M, Hagglund H, Nicoloso de Faveri G, et al. Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transpl. 2013;48:220–5.

    Article  CAS  Google Scholar 

  5. Shaw BE, Ball L, Beksac M, Bengtsson M, Confer D, Diler S, et al. Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations. Bone Marrow Transpl. 2010;45:832–8.

    Article  CAS  Google Scholar 

  6. Holig K, Kramer M, Kroschinsky F, Bornhauser M, Mengling T, Schmidt AH, et al. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood. 2009;114:3757–63.

    Article  PubMed  Google Scholar 

  7. Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, et al. Significant improvements in the practice patterns of adult related donor care in US transplantation centers. Biol Blood Marrow Transpl. 2016;22:520–7.

    Article  Google Scholar 

  8. Clare S, Mank A, Stone R, Davies M, Potting C, Apperley JF, et al. Management of related donor care: a European survey. Bone Marrow Transpl. 2010;45:97–101.

    Article  CAS  Google Scholar 

  9. O’Donnell PV, Pedersen TL, Confer DL, Rizzo JD, Pulsipher MA, Stroncek D, et al. Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States. Blood. 2010;115:5097–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kodera Y, Yamamoto K, Harada M, Morishima Y, Dohy H, Asano S, et al. PBSC collection from family donors in Japan: a prospective survey. Bone Marrow Transpl. 2014;49:195–200.

    Article  CAS  Google Scholar 

  11. Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transpl. 2013;48:452–8.

    Article  CAS  Google Scholar 

  12. Ruesch M, Amar El Dusouqui S, Buhrfeind E, Buser A, Chalandon Y, Frey BM, et al. Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors - first 10 years of prospective donor follow-up of Swiss donors. Bone Marrow Transpl. 2022;57:918–24.

    Article  CAS  Google Scholar 

  13. Anthias C, Ethell ME, Potter MN, Madrigal A, Shaw BE. The impact of improved JACIE standards on the care of related BM and PBSC donors. Bone Marrow Transpl. 2015;50:244–7.

    Article  CAS  Google Scholar 

  14. Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, et al. Health-related quality of life among older related hematopoietic stem cell donors (>60 Years) is equivalent to that of younger related donors (18 to 60 Years): a related donor safety study. Biol Blood Marrow Transpl. 2017;23:165–71.

    Article  Google Scholar 

  15. Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, et al. Effect of aging and predonation comorbidities on the related peripheral blood stem cell donor experience: report from the related donor safety study. Biol Blood Marrow Transpl. 2019;25:699–711.

    Article  Google Scholar 

  16. Lysak D, Koristek Z, Gasova Z, Skoumalova I, Jindra P. Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere? J Clin Apher. 2011;26:9–16.

    Article  PubMed  Google Scholar 

  17. Murata M, Harada M, Kato S, Takahashi S, Ogawa H, Okamoto S, et al. Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors. Bone Marrow Transpl. 1999;24:1065–71.

    Article  CAS  Google Scholar 

  18. Ings SJ, Balsa C, Leverett D, Mackinnon S, Linch DC, Watts MJ. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. Br J Haematol. 2006;134:517–25.

    Article  PubMed  Google Scholar 

  19. Bailen R, Perez-Corral AM, Pascual C, Kwon M, Serrano D, Gayoso J, et al. Factors predicting peripheral blood progenitor cell mobilization in healthy donors in the era of related alternative donors: Experience from a single center. J Clin Apher. 2019;34:373–80.

    Article  PubMed  Google Scholar 

  20. Suzuya H, Watanabe T, Nakagawa R, Watanabe H, Okamoto Y, Onishi T, et al. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sang. 2005;89:229–35.

    Article  CAS  PubMed  Google Scholar 

  21. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, et al. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors. Haematologica. 2019;104:844–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Farhadfar N, Ahn KW, Bo-Subait S, Logan B, Stefanski HE, Hsu JW, et al. The impact of pre-apheresis health related quality of life on peripheral blood progenitor cell yield and donor’s health and outcome: secondary analysis of patient-reported outcome data from the rdsafe and bmt ctn 0201 clinical trials. Transpl Cell Ther. 2022;28(603):e1–7.

    Google Scholar 

Download references

Acknowledgements

The authors are grateful for the work of all the physicians and data managers who contributed valuable related donor data to the Related Hematopoietic Stem Cell Donor Registry Center.  

Funding

None to disclose.

Author information

Authors and Affiliations

Authors

Contributions

RY designed the study, analyzed data, and wrote the manuscript. TH, HY, and NT designed the study, advised on methods, and wrote the manuscript. ND, KI, KM, TF, HN, SO, NH, JI, TA, MT, YK, TK, YM, and YK collected data and revised the manuscript. MH, and HY collected data, revised the manuscript, and were responsible for data management at JDCHCT. YA managed the unified registry database and revised the manuscript. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Ryu Yanagisawa.

Ethics declarations

Conflict of interest

M.H. received research grants and lecture fees from Kyowa Kirin Co. Ltd. and Chugai Pharma Co. Ltd. The other authors declare that they have no conflicts of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (XLSX 23 KB)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yanagisawa, R., Hirakawa, T., Doki, N. et al. Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors. Int J Hematol 117, 421–427 (2023). https://doi.org/10.1007/s12185-022-03489-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-022-03489-4

Keywords

Navigation